Found 13 matching trials
Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing PHASE2 Patients with salivary gland carcinoma were divided into groups according t...
Show More Learn More & Join Trial
Toripalimab Combined With Anlotinib, Etoposide and Platinum in the Treatment of Extensive-stage Small Cell Lung Cancer NA To evaluates the effectiveness and safety of Toripalimab combined with Anlo...
Show More Location
Daping Hospital, Third Military Medical University
Learn More & Join Trial
GAPP Induction and Concurrent Chemoradiotherapy Followed by Toripalimab Maintenance for Nasopharyngeal Carcinoma. PHASE2 In order to explore the efficacy and safety of targeted therapy and immunot...
Show More Location
Sun yat-sen University Cancer Center
Learn More & Join Trial
Open-Label, Biomarker-Integrated Umbrella Trial for First-Line Treatment of Extensive-stage Small Cell Lung Cancer PHASE2 This is an open-label umbrella study conducted in first treatment ES-SCLC p...
Show More Location
Tianjin Medical University Cancer Institute and Hospital, Tianjin, China 300060
Learn More & Join Trial
Toripalimab Plus Anlotinib for the Maintenance of Extensive Stage Small Cell PHASE3 This is a randomized, open, multicenter Phase III clinical study. A total o...
Show More Location
Multiple Locations
Learn More & Join Trial
Anlotinib, Toripalimab and Nab-paclitaxel in Locally Advanced/Metastatic Pancreatic Cancer PHASE2 This is an open-label, non-randomized, single-arm phase Ⅱ study aiming to e...
Show More Location
The First Affiliated Hospital of Nanjing Medical University
Learn More & Join Trial
A Phase III Study of First-line Anlotinib Combined With Benmelstobart in Patients With Advanced Esophageal Squamous Cell Carcinoma PHASE3 A Randomized, Open-Label, Parallel-Controlled, Multicenter Phase III Clinic...
Show More Location
The First Affiliated Hospital of Zhengzhou University
Learn More & Join Trial
Neoadjuvant Therapy of Anlotinib Combined With Toripalimab and Chemotherapy for Resectable Esophageal Carcinoma PHASE2 The purpose of this study is to explore the effectiveness and safety of the...
Show More Location
Multiple Locations
Learn More & Join Trial
GAPP Induction and Concurrent Chemoradiotherapy for High-risk Locoregionally Advanced NPC. PHASE3 The investigators have designed a multicenter, open-label, randomized contr...
Show More Location
Sun yat-sen university cancer center
Learn More & Join Trial
Toripalimab in Combination With Chemotherapy and Antiangiogenic Agents in Patients With Non-Small Cell Lung Cancer After Failure of Immunotherapy (PD-1/L1 Inhibitors) PHASE2 This is a phase II, single arm, open-label, single-center study to evaluate...
Show More Location
Multiple Locations
Learn More & Join Trial